Barbara Itzel Peña-Espinoza

Barbara Itzel Peña-Espinoza

Auto-generated profile, based on publicly available information

Barbara Itzel Peña-Espinoza

Laboratorio de Genómica de Enfermedades Complejas Facultad de Química, Unidad Académica de Ciencia y Tecnología de la UNAM en Yucatán Yucatán México

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
Katy Sanchez-PozosKaty Sanchez-Pozos
Katy Sanchez-Pozos
MOMA GUADALUPE ORTIZ
MA GUADALUPE ORTIZ
BPBárbara I. Peña-Espinoza
Bárbara I. Peña-Espinoza
MGMaría de Los Ángeles Granados-Silvestre
María de Los Ángeles Granados-Silvestre
VJVeronica Jimenez-Jacinto
Veronica Jimenez-Jacinto
MIMarta Menjívar Iraheta
Marta Menjívar Iraheta

1 August 2017 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
BPBarbara Itzel Peña-Espinoza
Barbara Itzel Peña-Espinoza
MGMaría de Los Ángeles Granados-Silvestre
María de Los Ángeles Granados-Silvestre
Katy Sanchez-PozosKaty Sanchez-Pozos
Katy Sanchez-Pozos
MOMA GUADALUPE ORTIZ
MA GUADALUPE ORTIZ
MIMarta Menjívar Iraheta
Marta Menjívar Iraheta

28 October 2016 in Pharmacogenomics
Verified
Journal Article
Closed access
Katy Sanchez-PozosKaty Sanchez-Pozos
Katy Sanchez-Pozos
CRCarolina Rivera-Santiago
Carolina Rivera-Santiago
MGMaría Helena García-Rodríguez
María Helena García-Rodríguez
MOMA GUADALUPE ORTIZ
MA GUADALUPE ORTIZ
BPBarbara Itzel Peña-Espinoza
Barbara Itzel Peña-Espinoza
MIMarta Menjívar Iraheta
Marta Menjívar Iraheta
Aim: CYP2C9 is one of the major drug metabolizing enzymes, however, little is known about polymorphisms in CYP2C9 gene and pharmacological implications in Mexican indigenous populations. Thus, frequencies of CYP2C9*2 and CYP2C9*3 alleles were evaluated in indigenous groups located in northwest (Cora), center (Mazahua and Teenek), south (Chatino and Mixteco) and southeast (Chontal and Maya) regions Mexico. Materials & methods: Allelic discrimination was performed by real-time PCR. Results: CYP2C9*2 allele was found only in Chontal and Maya groups, despite the low contribution of Caucasian component in these populations. CYP2C9*3 allele was present in all populations except in Mazahua, showing a wide genetic variability in the studied populations. Interestingly, we found significant differences between indigenous groups in CYP2C9*3 allele, even in groups located at the same region and belonging to the same linguistic family. Conclusion: These results contribute to laying the pharmacogenetic bases in Mexico,...

12 April 2026 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Open access
PDF file
MIMarta Menjívar Iraheta
Marta Menjívar Iraheta
EBErandi Bravo
Erandi Bravo
MRMargarita Rivera‐Balancan
Margarita Rivera‐Balancan
BEBarbara Itzel Pena Espinoza
Barbara Itzel Pena Espinoza
Major depression and suicide are critical public health concerns, particularly in underrepresented populations with unique genetic and sociocultural contexts. The Maya‐mestizo population presents the highest suicide rates in the country but remains understudied in psychiatric genetics. This study evaluated the association between three genetic variants, rs7305115 ( TPH2 ), rs6265 ( BDNF ), and rs2428707 ( HTR2C ), and the presence of major depression, melancholic subtype, and suicide risk in Maya‐mestizo adults. A total of 598 participants were recruited from urban and rural areas. Psychiatric evaluations were performed using the MINI 5.0 (DSM‐IV), and functional status was assessed with the Karnofsky scale. Genotyping was performed with TaqMan assays, and ancestry was confirmed with ancestry‐informative markers. Analyses included Hardy–Weinberg equilibrium testing and logistic regression models adjusted for sex and included age, body mass index, Karnofsky performance scale score, and sociodemographic variables as covariates. The prevalence of major depression was 38.9%, while suicide risk reached 24.7%. The rs2428707 variant of HTR2C was significantly associated with major depression (OR 2.31, 95% CI 1.03–5.18, p = 0.041). Variants in TPH2 and BDNF were associated with the melancholic subtype. No statistically significant associations were found with suicide risk, though overlap with depressive phenotypes suggests shared vulnerability. This first report of psychiatric genetics in the Maya‐mestizo population highlights the need for culturally and genetically tailored interventions.